Dysregulation of FOXO1 (Forkhead Box O1 Protein) Drives Calcification in Arterial Calcification due to Deficiency of CD73 and Is Present in Peripheral Artery Disease

William J. Moorhead, William J. Moorhead, Claire C. Chu, Claire C. Chu, Rolando A. Cuevas, Rolando A. Cuevas, Jack Callahan, Jack Callahan, Ryan Wong, Ryan Wong, Cailyn Regan, Cailyn Regan, Camille K. Boufford, Camille K. Boufford, Swastika Sur, Swastika Sur, Mingjun Liu, Mingjun Liu, Delphine Gomez, Delphine GomezJason N. Mactaggart, Alexey Kamenskiy, Manfred Boehm, Cynthia St. Hilaire, Cynthia St. Hilaire, Cynthia St. Hilaire, Cynthia St. Hilaire, Cynthia St. Hilaire, Cynthia St. Hilaire

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Objective: The recessive disease arterial calcification due to deficiency of CD73 (ACDC) presents with extensive nonatherosclerotic medial layer calcification in lower extremity arteries. Lack of CD73 induces a concomitant increase in TNAP (tissue nonspecific alkaline phosphatase; ALPL), a key enzyme in ectopic mineralization. Our aim was to investigate how loss of CD73 activity leads to increased ALPL expression and calcification in CD73-deficient patients and assess whether this mechanism may apply to peripheral artery disease calcification. Approach and Results: We previously developed a patient-specific disease model using ACDC primary dermal fibroblasts that recapitulates the calcification phenotype in vitro. We found that lack of CD73-mediated adenosine signaling reduced cAMP production and resulted in increased activation of AKT. The AKT/mTOR (mammalian target of rapamycin) axis blocks autophagy and inducing autophagy prevented calcification; however, we did not observe autophagy defects in ACDC cells. In silico analysis identified a putative FOXO1 (forkhead box O1 protein) binding site in the human ALPL promoter. Exogenous AMP induced FOXO1 nuclear localization in ACDC but not in control cells, and this was prevented with a cAMP analogue or activation of A2a/2b adenosine receptors. Inhibiting FOXO1 reduced ALPL expression and TNAP activity and prevented calcification. Mutating the FOXO1 binding site reduced ALPL promoter activation. Importantly, we provide evidence that non-ACDC calcified femoropopliteal arteries exhibit decreased CD73 and increased FOXO1 levels compared with control arteries. Conclusions: These data show that lack of CD73-mediated cAMP signaling promotes expression of the human ALPL gene via a FOXO1-dependent mechanism. Decreased CD73 and increased FOXO1 was also observed in more common peripheral artery disease calcification.

Original languageEnglish (US)
Pages (from-to)1680-1694
Number of pages15
JournalArteriosclerosis, Thrombosis, and Vascular Biology
DOIs
StateAccepted/In press - 2020

Keywords

  • alkaline phosphatase
  • arteries
  • calcification
  • lower extremity

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Dysregulation of FOXO1 (Forkhead Box O1 Protein) Drives Calcification in Arterial Calcification due to Deficiency of CD73 and Is Present in Peripheral Artery Disease'. Together they form a unique fingerprint.

  • Cite this

    Moorhead, W. J., Moorhead, W. J., Chu, C. C., Chu, C. C., Cuevas, R. A., Cuevas, R. A., Callahan, J., Callahan, J., Wong, R., Wong, R., Regan, C., Regan, C., Boufford, C. K., Boufford, C. K., Sur, S., Sur, S., Liu, M., Liu, M., Gomez, D., ... St. Hilaire, C. (Accepted/In press). Dysregulation of FOXO1 (Forkhead Box O1 Protein) Drives Calcification in Arterial Calcification due to Deficiency of CD73 and Is Present in Peripheral Artery Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 1680-1694. https://doi.org/10.1161/ATVBAHA.119.313765